Canyon Pharmaceuticals Announces Study Published in the Journal of Thrombosis and Haemostasis
PARSIPPANY, N.J.--(BUSINESS WIRE)--Orthopedic surgery patients with Stage 3B chronic kidney disease (CKD) are at high risk for blood clots despite standard treatment with the anticoagulant enoxaparin, according to a recently published study. Blood clots and post-operative bleeding were reduced with use of desirudin, a new type of anticoagulant.